BioNTech vs Evozyne
BioNTech vs Evozyne, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioNTech is on 66/100 and Evozyne on 55/100.
Where each one leads
BioNTech
- our overall score: 66/100 against 55/100
- domain rating: 74/100 against 31/100
- headcount: 5,128 against 54
- funding raised: $975M against $135M
Evozyne
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BioNTech | Evozyne |
|---|---|---|
| What it is | Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases. | AI-driven biotech company engineering novel proteins for therapeutics and sustainability. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, AI, Drug Discovery, Generative AI |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotechnology | Platform |
| Founded | 2008 | 2020 |
| Headquarters | Mainz, Germany | Chicago, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BioNTech | Evozyne |
|---|---|---|
| Employees | 5,128 | 54 |
| Total funding | $975M | $135M |
| Latest round | Loan | Series B |
| LinkedIn followers | 295,812 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioNTech | Evozyne |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 66/100 | 55/100 |
| Traction | 60/100 | 57/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 35/100 | 9/100 |
| Quality | 78/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 74/100 | 31/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioNTech | Evozyne |
|---|---|---|
| Hosting | Azure | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
BioNTech vs Evozyne: common questions
Which is better, BioNTech or Evozyne?
On our 0-100 score BioNTech rates higher (66/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do BioNTech and Evozyne compare on the numbers?
BioNTech leads on our overall score (66/100 against 55/100), domain rating (74/100 against 31/100), headcount (5,128 against 54), funding raised ($975M against $135M).
Read the full BioNTech review and pricing or the Evozyne review and pricing. You can also browse other BioNTech alternatives we track.